$WHG

Westwood Holdings Posts Q1 2026 Results, Raises Dividend

Westwood Holdings Group (WHG) reported robust Q1 2026 results, with assets under management and advisement rising to $18.3 billion, driven by strength in energy strategies, ETF growth, and a successful close for its Secondaries Fund II. Despite a sequential dip in revenue, year-over-year earnings improved, the company maintained a debt-free balance sheet, and its board approved a quarterly cash dividend of $0.15 per common share. TipRanks' AI Analyst, Spark, rated WHG as "Outperform," citing improved profitability and a strong balance sheet balanced against volatile earnings and net outflows.

Original reporting
TipRanks · TipRanks Auto-Generated Newsdesk
Published May 1, 2026, 5:39 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI May 1, 2026, 6:00 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Westwood Holdings Posts Q1 2026 Results, Raises Dividend — source image
Decision brief

The 30-second read

$WHGBullishMed
01

Why it matters

The company's strong fundamentals and positive analyst outlook suggest potential for stock appreciation, though market conditions and sector performance will influence actual price movements.

02

Market read

The news is relevant for investors and traders interested in asset management, energy sector, and ETF markets, with moderate impact on WHG stock price.

03

What to watch

Potential risks include market-wide downturns, interest rate fluctuations affecting asset valuations, or underperformance in energy strategies despite current results.

Relevance 6/10Timing: Immediate to short-term (next 1-3 months)

Background

Westwood Holdings Group reported Q1 2026 results highlighting growth in assets under management, driven by energy strategies and ETF expansion, with a maintained debt-free balance sheet and increased dividends.

Company-level read

Ticker impact

$WHGBullishHigh confidence
Context

Primary focus of the news, given the company's earnings report and dividend increase.

Expected impact

Moderate upward movement in stock price over the next 1-3 months, contingent on sustained earnings performance and market conditions.

Evidence & confidence

Strong quarterly results, dividend increase, and positive analyst rating indicate improved fundamentals and investor confidence, likely supporting stock appreciation.

Market effects

The energy sector and ETF markets may see increased investor interest due to WHG's performance and strategies.

Primarily US-focused, with limited regional impact beyond North America.

Limited; company-specific news with minimal direct global market influence.

Counterpoint

The positive earnings and dividend news may already be priced in, and short-term volatility or profit-taking could lead to price corrections.

Key entities

  • Westwood Holdings Group

    Asset management firm with focus on energy strategies and ETFs.

Related articles

$WHGMed

Westwood Holdings (WHG) Q2 2026 Earnings Call Transcript

Westwood Holdings Group (WHG) reported Q2 2026 revenues of $25.3 million and net income of $1.5 million, or $0.17 per diluted share. Economic earnings were $3.0 million, or $0.33 per share. Assets under management were $17.0 billion after $1.6 billion net outflows. The firm said its ETF, private capital, and managed solutions segments each exceed $500 million and noted the PWRX ETF will list mid-September on the Texas Stock Exchange.

$WHGMed

Westwood Holdings Group, Inc. Reports Second Quarter 2026 Results

WESTWOOD HOLDINGS GROUP INC (WHG) filed an SEC Form 8-K — Results of Operations and Financial Condition. Westwood Holdings Group, Inc. Reports Second Quarter 2026 Results Private Capital platform surpassed $500 million in assets Managed Investment Solutions flows reached $350 million Dallas, TX, August 6, 2026 – Westwood Holdings Group, Inc. (NYSE: WHG) today reported second quarter

$CMPXMedAI 8/10

Compass Therapeutics publishes tovecimig trial results in JCO

Compass Therapeutics (NASDAQ:CMPX) published Phase 2/3 trial results for tovecimig in the Journal of Clinical Oncology. The study met primary and secondary endpoints, showing improved response rates and progression-free survival in advanced biliary tract cancer patients compared to paclitaxel alone. However, overall survival showed no significant difference, and adverse events were higher in the combination arm. Tovecimig remains investigational.